UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2022
Commission
File Number: 001-39600
EQONEX
LIMITED
(Translation
of registrant’s name into English)
118
Piccadilly
Mayfair,
London WIJ 7NW
United
Kingdom
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION
CONTAINED IN THIS REPORT ON FORM 6-K
Singapore
Statutory Financial Statements
EQONEX
LIMITED (the “Company”) has, in connection with its Annual General Meeting of Shareholders (the “Annual General
Meeting”) to be held on November 29, 2022 and in accordance with Singapore law, prepared Singapore statutory financial statements
for the Company and its subsidiaries (collectively, the “Group”) for the year ended March 31, 2022, to be delivered
to the Company’s shareholders prior to the Annual General Meeting. The Singapore statutory financial statements were prepared in
accordance with the provisions of the Singapore Companies Act and the Singapore Financial Reporting Standards (International) issued
by the Accounting Standards Council which are simultaneously compliant with the International Financial Reporting Standards issued by
the International Accounting Standards Board.
Going
Concern Assumption
In
preparing the Singapore statutory financial statements, management of the Group has given careful consideration to the going concern
status of the Group in light of the fact that the Group has incurred a loss for the year of $75,819,128 and cash outflows from operating
activities of $42,607,632 for the year ended March 31, 2022, and as of that date, the Group had net current assets of $4,155,521 and
net assets of $4,098,206, among which the Group had cash and cash equivalents of $4,882,410 and a non-current convertible loan (the “Bifinity
Loan”) of $2,774,692, which was under a $36 million convertible loan agreement (the “Loan Agreement”) with
Bifinity UAB (“Bifinity”) with details set out in Note 30 to the consolidated financial statements contained in the
Company’s annual report for the year ended March 31, 2022 on Form 20-F filed with the Securities and Exchange Commission on August
15, 2022.
Subsequent
to March 31, 2022, the end of the reporting period of the Singapore statutory financial statements, the Group is currently in breach
of certain provisions of the Loan Agreement and consequently seeking a waiver from Bifinity on such breaches. Pursuant to a third amendment
agreement to the Loan Agreement entered into by the Company and Bifinity on September 30, 2022, the drawdown of the fifth tranche of
the Bifinity Loan was postponed from September 15, 2022 to October 27, 2022. Up to the date of this Form 6-K, the fifth tranche of the
Bifinity Loan has not been drawn down. Based on the working capital forecast prepared by management of the Group, the financial resources
available to the Group as of March 31, 2022 and up to the date of this Form-6-K may not be sufficient to satisfy the working capital
requirements of the Group for a period of twelve months from the date of this 6-K, which may cast significant doubt on the Group’s
ability to continue as a going concern. The Group is pursuing financing options including, but not limited to, equity financing from
the issuance of new shares, where negotiation with potential investors is ongoing as of the date of this Form 6-K.
The
above conditions indicate the existence of a material uncertainty which may cast significant doubt on the Group’s ability to continue
as a going concern. Management has reviewed the Group’s cash flow projections which cover a period of not less than twelve months
from the date of this Form 6-K, and is of the opinion that the Group will not have sufficient working capital to meet its financial obligations
that will be due in the coming twelve months from the date of this Form 6-K, and the on-going covenants compliance under the Loan Agreement
unless one or both of the following efforts are successful or other sources of funding are found: (i) agreeing with Bifinity on amendments
to the Loan Agreement; and/or (ii) raising equity financing through the issuance of new shares. If the Group had sufficient working capital
to meet its cash flow requirements in the next twelve months from the date of this Form 6-K, then management is of the opinion that it
would be appropriate to prepare the Singapore statutory financial statements on a going concern basis.
Notwithstanding
the above, significant uncertainties exist as to whether the Group can achieve the plans and measures described above to generate adequate
cash inflow as scheduled. Should the Group be unable to operate as a going concern for the next twelve months from the date of this Form
6-K, adjustments would have to be made to reduce the carrying values of the Group’s assets to their realizable values, to provide
for financial liabilities which might arise, and to reclassify non-current assets and non-current liabilities as current assets and current
liabilities, respectively. The effects of these adjustments have not been reflected in the Singapore statutory financial statements.
Subsequent
Events
Subsequent
to March 31, 2022, the end of the reporting period of the Singapore statutory financial statements, the second, third and fourth tranches
of the Bifinity Loan with an aggregate amount of $15 million have been drawn down by the Group and were paid by Bifinity. On September
30, 2022, the Company entered into a third amendment agreement to the Loan Agreement with Bifinity, pursuant to which the drawdown date
of the fifth tranche of the Bifinity Loan of $9 million was postponed from September 15, 2022 to October 27, 2022. Up to the date of
this Form 6-K, the fifth tranche of the Bifinity Loan has not been drawn down.
Audit
of Singapore Statutory Financial Statements
The
Company engaged an independent accounting firm in Singapore to audit the Singapore statutory financial statements in accordance with
Singapore Standards on Auditing and to issue an auditor’s report. In the auditor’s report, the Singapore audit firm did not
express an opinion on the Singapore statutory financial statements. Because of the significance of the matters described above, the Singapore
audit firm was not able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on the Singapore statutory
financial statements.
The
auditor’s report stated that the conditions mentioned above indicated the existence of material uncertainties which may cast significant
doubts on the ability of the Group and the Company to continue as a going concern.
The
Singapore audit firm was not able to obtain sufficient audit evidence regarding the likely outcome of the Group’s ability to obtain
the financing arrangements mentioned above. Accordingly, they are uncertain of the appropriateness of the use of the going concern assumption
in the preparation of the Singapore statutory financial statements.
In
addition, in view of the significance of the matters referred to above, the Singapore audit firm did not express an opinion on whether
the accounting and other records required by the Singapore Companies Act 1967 to be kept by the Company and those subsidiary corporations
incorporated in Singapore of which they are the auditors, have been properly kept in accordance with the provisions of such Act.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
EQONEX
LIMITED |
|
|
|
Date:
November 15, 2022 |
By: |
/s/
Daniel Ling |
|
Name: |
Daniel
Ling |
|
Title: |
Chief
Financial Officer |
Eqonex (NASDAQ:EQOS)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Eqonex (NASDAQ:EQOS)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025